Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins
about
Prominin-2 expression increases protrusions, decreases caveolae and inhibits Cdc42 dependent fluid phase endocytosisCD133: to be or not to be, is this the real question?Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)A novel mouse HSF3 has the potential to activate nonclassical heat-shock genes during heat shockGene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeCells previously identified as retinal stem cells are pigmented ciliary epithelial cells.Identification of the neuromuscular junction transcriptome of extraocular muscle by laser capture microdissection.Prominin-1 Is a Novel Regulator of Autophagy in the Human Retinal Pigment EpitheliumHuman prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.Autosomal recessive retinitis pigmentosa with early macular affectation caused by premature truncation in PROM1.Distinct and conserved prominin-1/CD133-positive retinal cell populations identified across speciesThe PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy.Prom1 function in development, intestinal inflammation, and intestinal tumorigenesisSpatial distribution of prominin-1 (CD133)-positive cells within germinative zones of the vertebrate brain.Expression of human skin-specific genes defined by transcriptomics and antibody-based profilingLovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells.The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia.Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.Targeting CD133 antigen in cancer.The heat shock factor family and adaptation to proteotoxic stress.Concise review: transmissible animal tumors as models of the cancer stem-cell process.CD133+ cells as a therapeutic target for kidney diseases.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.Molecular basis for photoreceptor outer segment architecture.CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.Commentary: "prom1 function in development, intestinal inflammation, and intestinal tumorigenesis".Identification of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues.CD133 and membrane microdomains: old facets for future hypotheses.CD133 mRNA may be a suitable prognostic marker for human breast cancer.Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.Nomenclature of prominin-1 (CD133) splice variants - an update.Prominin-2 Prevents the Formation of Caveolae in Normal and Ovarian Hyperstimulated Pregnancy.
P2860
Q24338447-7FE74C78-8CA6-4697-9464-8147817FCE52Q24615405-AD3A2EC2-E703-4A14-BC11-6EF852EC5F3FQ27320830-54F38248-9341-43F5-AF4E-A1932533D546Q28594783-64197794-85A8-41F5-B67A-954C67769AE9Q29011337-62E79673-0594-4E20-8DE3-8ECF34712A56Q30487175-53A45874-436F-4DFE-A692-FF559FD1C8D9Q33555795-D4E28AB0-562D-4A6E-8999-A607A9C20194Q33597425-0568C935-EAE3-477C-9D8C-ACA117E0FF36Q33728631-AD6AD10D-B08F-49C8-8740-D12641930E57Q33845550-3C38397E-8499-41DE-A4B4-AEDA206F5D5FQ33847008-76BB4CDD-9193-446B-9654-6D9F138DF170Q34135469-D41F5018-5E1D-44A9-8075-0BF888B1CFA2Q34510512-BB7C4750-ECAE-4D46-AE25-4F069ED05EC6Q34749277-9573624C-CEC7-4F8F-94D3-BE39C380E82DQ35009795-6A9CCA5C-6F6A-4C73-AB08-67CB3C6B5CC8Q36928209-EB79B423-FFD0-4ED6-BECC-791FFB43C12CQ36942469-37794F45-598E-40A1-83F0-E5B2D8297C25Q37004685-A56A7A3F-BF42-479C-9C4A-4CFBF18D6CF0Q37521082-E85930F7-0E16-411F-AABC-1475C48D8CF0Q37800068-FBCA7A82-9ABD-44E4-BFE6-E61DE9DEC497Q37940396-19E5D1CE-DA70-4987-A0E2-1CCBD26C0D44Q37983119-04E5A85B-D377-4E0C-9569-FFFF924F57A6Q38035206-4164B44E-9A01-493F-BAC6-2179ABF21FF8Q38853535-FFD95A2E-84F2-4F43-9BBE-8B3BB923BA8FQ38922806-C49810AE-5298-4200-B697-E71699DD447DQ38937280-3F805D43-D836-45B0-A0FA-2A604AD6D9C2Q39833209-96BCFE35-0740-4082-9A35-F23EA0212DD4Q42747326-3EBB40A0-5317-4134-8B8A-CE4716BBBDCEQ42951300-A7DB6036-9C3C-44FB-942F-DFC7B58938BBQ47101214-D70748CA-E648-43BD-B05D-0847D117BE50Q47221138-A300A662-0F7E-4DE7-97F3-7919FA3BFD81Q48692740-0A391F57-F147-49B1-B42C-96EA83BC5D81Q50118631-7E00B0CA-14D6-4C5F-B325-9D7323F61469
P2860
Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@ast
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en-gb
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@nl
type
label
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@ast
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en-gb
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@nl
prefLabel
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@ast
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en-gb
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@nl
P2093
P2860
P3181
P356
P1476
Characterization of prominin-2 ...... ntaspan membrane glycoproteins
@en
P2093
Christine A Fargeas
Mareike Florek
Wieland B Huttner
P2860
P304
P3181
P356
10.1074/JBC.M210640200
P407
P577
2003-01-03T00:00:00Z